Antonio Luza
Physician Assistant · Sacramento, CANPI 1891773834
Payments from drug & device makers
Across 936 payments — averaging $28.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$3K
- Neurocrine Biosciences, Inc.$3K
- E.r. Squibb & Sons, L.L.C.$2K
- Almatica Pharma LLC$2K
- Otsuka America Pharmaceutical, Inc.$2K
- Sunovion Pharmaceuticals Inc.$2K
- plus $12K from 36 others
What the payments were for
- Consulting fees$2,98011%
- Food & beverage$23,39289%
- Education$510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOREEV XR$1,784
- INGREZZA$1,015
- LYBALVI$956
- ABILIFY MAINTENA$726
- SPRAVATO$498
- ABILIFY ASIMTUFII$492
- COBENFY$457
- ARISTADA$445
- INVEGA SUSTENNA$367
- CAPLYTA$352
- REXULTI$351
- Fanapt$349
- UZEDY$344
- Kerendia$247
- The Cologuard Plus Collection Kit$236
- AUSTEDO$212
- AMYVID$125
- NEUROSTAR TMS THERAPY SYSTEM$123
- Austedo XR$122
- BREZTRI$121
How this compares
$26,424 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 38 | $317,862 |
| VraylarCariprazine Hcl | 163 | $255,701 |
| Invega SustennaPaliperidone Palmitate | 63 | $192,195 |
| Austedo XrDeutetrabenazine | 21 | $139,772 |
| Abilify AsimtufiiAripiprazole | 22 | $119,422 |
| FanaptIloperidone | 38 | $97,674 |
| AtivanLorazepam | 22 | $95,419 |
| CaplytaLumateperone Tosylate | 32 | $68,997 |
| RexultiBrexpiprazole | 45 | $66,510 |
| Abilify MaintenaAripiprazole | 12 | $34,016 |
| Seroquel XrQuetiapine Fumarate | 19 | $30,469 |
| Lurasidone Hcl | 78 | $28,289 |
| Effexor XrVenlafaxine Hcl | 16 | $27,265 |
| TrintellixVortioxetine Hydrobromide | 48 | $27,024 |
| BelsomraSuvorexant | 58 | $24,514 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $2,831 | $317,86238 claims |
| AbbVieVraylar, Fetzima | $1,604 | $261,339175 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Asimtufii, Rexulti, Abilify Maintena | $2,185 | $219,94879 claims |
| Johnson & JohnsonInvega Sustenna | $1,263 | $192,19563 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $1,635 | $139,77221 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $1,232 | $97,67438 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $2,948 | $68,99732 claims |
| PfizerEffexor Xr | $22 | $27,26516 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $749 | $27,02448 claims |
| MerckBelsomra | $111 | $24,51458 claims |
| Sunovion Pharmaceuticals Inc.Latuda | $1,892 | $16,75212 claims |
| Lilly USA, LLCCymbalta, Olanzapine | $567 | $12,216280 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Sacramento
- Franklin ClineSacramento$458K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Eric CheungLos Angeles$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.